Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

Autor: Pagano, Livio, Salmanton-Garcia, J., Marchesi, F., Blennow, O., Gomes da Silva, M., Glenthoj, A., van Doesum, J., Bilgin, Y. M., Lopez-Garcia, A., Itri, F., Nunes Rodrigues, R., Weinbergerova, B., Farina, F., Dragonetti, Giulia, Berg Venemyr, C., van Praet, J., Jaksic, O., Valkovic, T., Falces-Romero, I., Martin-Perez, S., Jimenez, M., Davila-Valls, J., Schonlein, M., Ammatuna, E., Meers, S., Delia, M., Stojanoski, Z., Nordlander, A., Lahmer, T., Imre Pinczes, L., Buquicchio, C., Piukovics, K., Ormazabal-Velez, I., Fracchiolla, N., Samarkos, M., Mendez, G. -A., Hernandez-Rivas, J. -A., Espigado, I., Cernan, M., Petzer, V., Lamure, S., di Blasi, R., Marques de Almedia, J., Dargenio, M., Biernat, M. M., Sciume, M., de Ramon, C., de Jonge, N., Batinic, J., Aujayeb, A., Marchetti, M., Fouquet, G., Fernandez, N., Zambrotta, G., Sacchi, M. V., Guidetti, A., Demirkan, F., Prezioso, L., Racil, Z., Nucci, M., Mladenovic, M., Lievin, R., Hanakova, M., Grafe, S., Sili, U., Machado, M., Cattaneo, C., Adzic-Vukicevic, T., Verga, L., Labrador, J., Rahimli, L., Bonanni, Matteo, Passamonti, F., Pagliuca, A., Corradini, P., Hoenigl, M., Koehler, P., Busca, A., Cornely, O. A., Serrano, L., Ribera-Santa Susana, J. -M., Meletiadis, J., Tsirigotis, P., Coppola, N., Mikulska, M., Erben, N., Besson, C., Merelli, M., Gonzalez-Lopez, T. -J., Loureiro-Amigo, J., Garcia-Vidal, C., Kort, E. D., Cuccaro, A., Zompi, S., Reizine, F., Finizio, O., Dulery, R., Calbacho, M., Abu-Zeinah, G., Malak, S., Zdziarski, P., Varrichio, G., Tragiannidis, A., Plantefeve, G., Duarte, R., Danion, F., Tisi, M. C., Sakellari, I., Karthaus, M., Groh, A., Fung, M., Emarah, Z., Coronel-Ayala, O. -F., Ann Chai, L. Y., Brehon, M., Bonuomo, V., Wolf, D., Wittig, J., Vehreschild, M., Papa, M. V., Neuhann, J., Jimenez-Lorenzo, M. -J., Grothe, J., Gavriilaki, E., Garcia-Sanz, R., Garcia-Pouton, N., El-Ashwah, S. S., Eggerer, M., Cordoba, R., Colak, G. M., Arellano, E.

Publikováno v: Blood, 140(26), 2773-2787. American Society of Hematology
Blood
Volume 140
Issue 26
Blood, vol 140, iss 26
EPICOVIDEHA Survey members 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from the EPICOVIDEHA survey ', Blood, vol. 140, no. 26, pp. 2773-2787 . https://doi.org/10.1182/blood.2022017257
Blood, 140(26). AMER SOC HEMATOLOGY
Pagano, L, Salmanton-garcía, J, Marchesi, F, Blennow, O, Gomes Da Silva, M, Glenthøj, A, Van Doesum, J A, Bilgin, Y M, Lopez-garcia, A, Itri, F, Nunes Rodrigues, R, Weinbergerová, B, Farina, F, Dragonetti, G, Berg Venemyr, C, Van Praet, J, Jaksic, O, Valkovic, T, Falces-romero, I, Martin-perez, S, Jiménez, M, Davila-valls, J, Schonlein, M, Ammatuna, E, Meers, S, Delia, M, Stojanoski, Z, Nordlander, A, Lahmer, T, Pinczés, L I, Buquicchio, C, Piukovics, K, Ormazabal-velez, I, Fracchiolla, N S, Samarkos, M, Mendez, G, Hernández-rivas, J, Espigado, I, Cernan, M, Petzer, V, Lamure, S, Di Blasi, R, Marques De Almeida, J, Dargenio, M, Biernat, M M, Sciumè, M, De Ramón, C, De Jonge, N A, Batinic, J, Aujayeb, A, Marchetti, M, Fouquet, G, Fernández Escalada, N, Zambrotta, G P M, Sacchi, M V, Guidetti, A, Demirken, F, Prezioso, L, Racil, Z, Nucci, M, Mladenovic, M, Lievin, R, Hanakova, M, Grafe, S K, Sili, U, Machado, M, Cattaneo, C, Adzic-vukicevic, T, Verga, L, Labrador, J, Rahimli, L, Bonanni, M, Passamonti, F, Pagliuca, A, Corradini, P, Hoenigl, M, Koehler, P, Busca, A & Cornely, O A 2022, ' Breakthrough COVID-19 in vaccinated patients with hematologic malignancies : results from EPICOVIDEHA survey ', Blood, pp. 2773–2787 . https://doi.org/10.1182/blood.2022017257

Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti–severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Adult patients with HM, ≥1 dose of anti-SARS-CoV-2 vaccine, and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46d068f242283040ec3d5be079ebd89c
https://research.vumc.nl/en/publications/c62a76e2-fca2-45ed-a697-f1017ce3b6ec

ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity

Autor: Fontana, D, Mauri, M, Niro, A, Massimino, L, Bertagna, M, Zambrotta, G, Bossi, M, CITTERIO, STEFANIA, Crescenzi, B, Signore, G, Piazza, V, Mecucci, C, Cavaletti, G, Rea, D, Gambacorti-Passerini, C, Piazza, R

Atypical chronic myeloid leukemia (aCML) is a clonal disorder belonging to the myelodysplastic/myeloproliferative syndromes. About 13% of aCML cases carry somatic mutations in ETNK1 gene, encoding for H243Y, N244S, and G245V substitutions. We previou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1299::68e62819e201d4148f58dea112c1706b
http://hdl.handle.net/10281/205010

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.